21 results on '"Lockyer K"'
Search Results
2. A practical approach to production scheduling.
- Author
-
Bestwick, P. F. and Lockyer, K. G.
- Subjects
PRODUCTION scheduling ,INDUSTRIAL organization (Economic theory) ,OPERATIONS research ,MATRICES (Mathematics) ,ORGANIZATIONAL behavior ,MATHEMATICAL programming ,SYSTEMS theory - Abstract
The paper gives a practical, branch and hound based solution to the scheduling problem, as found in real life. Organizational aspects of solving the scheduling problem are considered, and two organizational ideas, 'the area of responsibility ' and ' the time span of action', are presented. Inteligibility to administrators and operatives of the output from any scheduling system is emphasized, and the adoption of a wholly new concept, the 'Generalized Ordered Schedule', is advocated as a means of achieving intuitive appeal and improved control. The requirements which any useful seheduling system must satisfy are identified, from field studies, and reported. Data are presented on a collection of real problems, and comparisons of decision rule solution procedures with the branch and bound procedure given. These demonstrate that the usually accepted results from conventional simulation and other techniques using artificial job 'operation time and technological route matrices are misleading. [ABSTRACT FROM AUTHOR]
- Published
- 1979
- Full Text
- View/download PDF
3. Glossary of Terms for the General Scheduling Problem
- Author
-
Bestwick, P. F. and Lockyer, K. G.
- Published
- 1975
- Full Text
- View/download PDF
4. The Teaching of Stock Control
- Author
-
Lockyer, K. G.
- Published
- 1969
- Full Text
- View/download PDF
5. Changes in the rate of heat production of calves during grazing and eating.
- Author
-
Holmes, C. W., McLean, N. A., and Lockyer, K. J.
- Published
- 1978
- Full Text
- View/download PDF
6. The Life Profile of Stock as a Control Measure.
- Author
-
Lockyer, K. G. and Wynne, R. M.
- Subjects
PRODUCTION control ,FINANCIAL statements ,FOREIGN exchange rates ,CONSUMPTION (Economics) - Abstract
The article discusses the use of the life profile of stock as a production control measure in Great Britain. Stock is a term used loosely in management to cover a variety of investments. In company accounts the item which appears on the balance sheet as stock is usually elaborated in the notes to the accounts as raw materials and consumables, work in progress and finished goods, effectively the BS 5191 definition. The balance sheet figure does not identify the magnitude of each item although this may be done by reference to the notes to the accounts. The most usual index to the control of stock is the stock turnover, defined as the rate of consumption of stock, frequently calculated by dividing the annual sales level by the level of stock. The weakness of stock turnover as an index from which actions can follow lies in the feet that it is a conglomerate figure bringing together a number of dissimilar components controlled by different actors inside and outside the organisation. For example, with no change in the behaviour of any part of the organisation, a movement of the exchange rate can significantly affect the sales level and hence the stock turnover.
- Published
- 1989
- Full Text
- View/download PDF
7. The construction of examination timetables by computer.
- Author
-
Foxley, E. and Lockyer, K.
- Published
- 1968
8. THRESHOLD EXTENSION OF AN F.M. DEMODULATOR USING A DYNAMIC TRACKING FILTER
- Author
-
POST OFFICE RESEARCH DEPT LONDON (ENGLAND), Lockyer,K. S., POST OFFICE RESEARCH DEPT LONDON (ENGLAND), and Lockyer,K. S.
- Abstract
The paper describes the design and construction of an experimental dynamic tracking-filter demodulator developed as suitable for receiving wideband transmissions of frequency-division-multiplex (f.d.m.) telephony and television from a communications satellite. Some of the design aspects of the demodulator are considered, and a test to determine the effect of noise on the tracking signal is described. The salient features of the demodulator circuit are described in detail, and performance measurements of several demodulators receiving 24-, 60-, 120- and 240-channel telephony transmissions are included, together with results of comparative tests using television signals. The results indicate that this type of demodulator performs at least as well as others currently available, and, owing to its small size and comparative simplicity, has advantages from an economic point of view. (Author), Revision of report dated 15 Jan 68.
- Published
- 1968
9. Glossary of Terms for the General Scheduling Problem
- Author
-
Bestwick, P. F., primary and Lockyer, K. G., additional
- Published
- 1975
- Full Text
- View/download PDF
10. The Application of the Matrix to “Activity-on-Node” Network Systems
- Author
-
Lockyer, K. G., primary
- Published
- 1967
- Full Text
- View/download PDF
11. The Teaching of Stock Control
- Author
-
Lockyer, K. G., primary
- Published
- 1969
- Full Text
- View/download PDF
12. Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y.
- Author
-
Chan H, Beresford N, Rudd TR, Rigsby P, Vipond C, Gao F, Matejtschuk P, Malik K, Duru C, Atkinson E, Burkin K, De Benedetto G, Lockyer K, and Bolgiano B
- Subjects
- Humans, Reference Standards, Vaccines, Conjugate, Neisseria meningitidis, Polysaccharides, Bacterial, Meningococcal Vaccines standards
- Abstract
Two candidate International Standards for meningococcal capsular group W and Y (MenW and MenY, respectively) polysaccharides were assessed for their suitability as quantitative standards in various physicochemical assays. The study was designed to evaluate the intended purpose of these standards, namely, to standardize the quantification of the respective polysaccharide content in meningococcal polysaccharide and conjugate vaccines and their intermediate components. Twelve laboratories from eleven different countries participated in the collaborative study of candidate preparations for International Standards for MenW and MenY polysaccharide (coded 16/152 and 16/206, respectively). Unitage was assigned using the Resorcinol assay. Our proposals, on the basis of data from the Resorcinol assay were: 1) candidate standard for MenW polysaccharide (16/152) to be assigned a content of 1.015 ± 0.071 mg MenW polysaccharide per ampoule (expanded uncertainty with coverage factor k = 2.13, corresponding to a 95 % level of confidence) and 2) candidate standard for MenY polysaccharide (16/206) be assigned a content of 0.958 ± 0.076 mg MenY polysaccharide per ampoule (expanded uncertainty with coverage factor k = 2.26, corresponding to a 95 % level of confidence). The amount of polysaccharide per ampoule remained consistent under all stability conditions over a 36-month period., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Crown Copyright © 2024. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
13. Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines.
- Author
-
Gao F, Lockyer K, Logan A, Davis S, Bolgiano B, Rijpkema S, Singh G, Prasad SD, Dondapati SP, and Sounkhla GS
- Abstract
Typhoid conjugate vaccines (TCV) are effective in preventing enteric fever caused by Salmonella enterica serovar Typhi in Southeast Asia and Africa. To facilitate vaccination with the Vi capsular polysaccharide-tetanus toxoid conjugate vaccine, Typbar TCV, and allow it to be transported and stored outside a cold chain just prior to administration, an extended controlled-temperature conditions (ECTC) study was performed to confirm the quality of the vaccine at 40 °C for 3 days at the end of its shelf-life (36 months at 2-8 °C). Studies performed in parallel by the vaccine manufacturer, Bharat Biotech International Limited, and an independent national control laboratory (NIBSC) monitored its stability-indicating parameters: O -acetylation of the Vi polysaccharide, integrity of the polysaccharide-protein conjugate, and its molecular size and pH. ECTC samples stored at 40 °C and 45 °C in comparison with control samples stored at 4 °C and 55 or 56 °C, were shown to have stable O -acetylation and pH; only very slight increases in the percentage of free saccharide and corresponding decreases in molecular size were observed. The deoxycholate method for precipitating conjugated polysaccharide was very sensitive to small incremental increases in percentage of free saccharide, in line with storage temperature and duration. This extended ECTC study demonstrated minimal structural changes to the Vi polysaccharide and conjugate vaccine and a stable formulation following extended exposure to elevated temperatures for the desired durations. This outcome supports the manufacturer's ECTC claim for the vaccine to be allowed to be taken outside the cold chain before its administration.
- Published
- 2021
- Full Text
- View/download PDF
14. Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.
- Author
-
Gao F, Beresford N, Lockyer K, Burkin K, Rigsby P, and Bolgiano B
- Subjects
- Antibodies, Bacterial, Immunogenicity, Vaccine, Meningococcal Infections prevention & control, Polysaccharides, Bacterial standards, Serogroup, Vaccine Potency, Vaccines, Conjugate chemistry, Vaccines, Conjugate standards, World Health Organization, Meningococcal Vaccines chemistry, Meningococcal Vaccines standards, Polysaccharides, Bacterial administration & dosage
- Abstract
Potency of meningococcal polysaccharide-protein conjugate vaccines relies on the polysaccharide content to prevent meningitis. NIBSC, as the official national control laboratory in UK, analysed ten different mono- and multi-meningococcal conjugate vaccines, using established International Standards for meningococcal serogroups A, C, W, Y and X, by resorcinol or HPAEC-PAD assay. Most saccharide contents were within ±20% of their claimed content for licensure with taking different O-acetylation levels into consideration, with only MenC content in two vaccines below (by 60% and 54%) the labelled value, however, previous study showed different dosage was not necessarily correlated to the immunogenicity of those vaccines. This study demonstrated the use of International Standards to quantify saccharide content in polysaccharide-based vaccines with different percentage of O-acetylation. These International Standards are suitable to serve as either quantitative standard or calibrator of in-house standards, with supplied stability data., (Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
15. Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.
- Author
-
Lockyer K, Gao F, Francis RJ, Eastwood D, Khatri B, Stebbings R, Derrick JP, and Bolgiano B
- Subjects
- Animals, Antibodies, Bacterial, Immunoconjugates immunology, Mice, Polysaccharides, Bacterial immunology, Vaccines, Combined, Vaccines, Conjugate, Carbodiimides, Immunogenicity, Vaccine, Meningococcal Vaccines immunology, Neisseria meningitidis, Serogroup C immunology, Tetanus Toxoid immunology
- Abstract
To examine the link between meningococcal C (MenC) vaccine size and immunogenic response, a panel of MenC glycoconjugate vaccines were prepared differing in chain length, molar mass and hydrodynamic volume. The preparations consisted of different lengths of MenC polysaccharide (PS) covalently linked to monomeric purified tetanus toxoid (TT) carrier protein using the coupling reagent ethylcarbodiimide hydrochloride (EDC). Size exclusion chromatography with multi-angle light scattering (SEC-MALS) and viscometry analysis confirmed that the panel of MenC-TT conjugates spanned masses of 191,500 to 2,348,000 g/mol, and hydrodynamic radii ranging from 12.1 to 47.9 nm. The two largest conjugates were elliptical in shape, whereas the two smallest conjugates were more spherical. The larger conjugates appeared to fit a model described by multiple TTs with cross-linked PS, typical of lattice-like networks described previously for TT conjugates, while the smaller conjugates were found to fit a monomeric or dimeric TT configuration. The effect of vaccine conjugate size on immune responses was determined using a two-dose murine immunization. The two larger panel vaccine conjugates produced higher anti-MenC IgG1 and IgG2b titres after the second dose. Larger vaccine conjugate size also stimulated greater T-cell proliferative responses in an in vitro recall assay, although cytokines indicative of a T-helper response were not measurable. In conclusion, larger MenC-TT conjugates up to 2,348,000 g/mol produced by EDC chemistry correlate with greater humoral and cellular murine immune responses. These observations suggest that conjugate size can be an important modulator of immune response., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
16. O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes.
- Author
-
Hitri K, Kuttel MM, De Benedetto G, Lockyer K, Gao F, Hansal P, Rudd TR, Beamish E, Rijpkema S, Ravenscroft N, and Bolgiano B
- Subjects
- Acetylation, Antibodies, Bacterial blood, Citrobacter freundii immunology, Humans, Immune Sera, Molecular Dynamics Simulation, Polysaccharides, Bacterial chemistry, Salmonella typhi immunology, Typhoid Fever prevention & control, World Health Organization, Immunodominant Epitopes immunology, Polysaccharides, Bacterial immunology, Typhoid-Paratyphoid Vaccines immunology
- Abstract
In this work, we explore the effects of O-acetylation on the physical and immunological characteristics of the WHO International Standards of Vi polysaccharide (Vi) from both Citrobacter freundii and Salmonella enterica serovar Typhi. We find that, although structurally identical according to NMR, the two Vi standards have differences with respect to susceptibility to de-O-acetylation and viscosity in water. Vi standards from both species have equivalent mass and O-acetylation-dependent binding to a mouse monoclonal antibody and to anti-Vi polyclonal antisera, including the WHO International Standard for human anti-typhoid capsular Vi PS IgG. This study also confirms that human anti-Vi sera binds to completely de-O-acetylated Vi. Molecular dynamics simulations provide conformational rationales for the known effect of de-O-acetylation both on the viscosity and antigenicity of the Vi, demonstrating that de-O-acetylation has a very marked effect on the conformation and dynamic behavior of the Vi, changing the capsular polysaccharide from a rigid helix into a more flexible coil, as well as enhancing the strong interaction of the polysaccharide with sodium ions. Partial de-O-acetylation of Vi revealed hidden epitopes that were recognized by human and sheep anti-Vi PS immune sera. These findings have significance for the manufacture and evaluation of Vi vaccines., (Copyright © 2019. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
17. Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi.
- Author
-
Gao F, Swann C, Rigsby P, Rijpkema S, Lockyer K, Logan A, and Bolgiano B
- Subjects
- Child, Humans, International Cooperation, Magnetic Resonance Spectroscopy, Typhoid Fever prevention & control, Typhoid-Paratyphoid Vaccines administration & dosage, Typhoid-Paratyphoid Vaccines standards, Vaccines, Conjugate administration & dosage, Vaccines, Conjugate immunology, Vaccines, Conjugate standards, World Health Organization, Citrobacter freundii immunology, Polysaccharides, Bacterial immunology, Salmonella typhi immunology, Typhoid Fever immunology, Typhoid-Paratyphoid Vaccines immunology
- Abstract
Numerous Vi capsular polysaccharide (Vi PS) conjugate vaccines to protect young children and infants from Typhoid are either licensed or under development. These vaccines are evaluated by laboratory methods to ensure their potency and that quality requirement are met. International Standard (IS) preparations of Vi PS are needed to calibrate and harmonise these assays. Twenty laboratories from 12 countries participated in a collaborative study to evaluate two candidate ISs: Citrobacter freundii Vi PS (NIBSC code 12/244) and Salmonella enterica serovar Typhi Vi PS (16/126). On the basis of returned results and stability profiles, these standards were established by the WHO Expert Committee on Biological Standardization in Oct 2017 as the First WHO IS for C. freundii Vi PS with a content of 1.94 ± 0.12 mg Vi PS per ampoule (expanded uncertainty with coverage factor of k = 2.11 corresponding to a 95% level of confidence) and the First WHO IS for S. Typhi Vi PS with a content of 2.03 ± 0.10 mg Vi PS per ampoule (expanded uncertainty with coverage factor of k = 2.11), as determined by quantitative NMR. The study also showed the ISs are suitable for physicochemical and immuno assays used for the quantitation of the Vi PS component in Vi PS and conjugate vaccines., (Copyright © 2018. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
18. Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.
- Author
-
Lockyer K, Gao F, Derrick JP, and Bolgiano B
- Subjects
- Animals, Antibodies, Monoclonal immunology, Carrier Proteins immunology, Enzyme-Linked Immunosorbent Assay, Epitope Mapping, Models, Molecular, Polysaccharides, Bacterial isolation & purification, Protein Folding, Rats, Tetanus Toxoid chemistry, Polysaccharides, Bacterial immunology, Tetanus Toxoid immunology, Vaccines, Conjugate chemistry, Vaccines, Conjugate immunology
- Abstract
An analysis of structure-antibody recognition relationships in nine licenced polysaccharide-tetanus toxoid (TT) conjugate vaccines was performed. The panel of conjugates used included vaccine components to protect against disease caused by Haemophilus influenzae type b, Neisseria meningitidis groups A, C, W and Y and Streptococcus pneumoniae serotype 18C. Conformation and structural analysis included size exclusion chromatography with multi-angle light scattering to determine size, and intrinsic fluorescence spectroscopy and fluorescence quenching to evaluate the protein folding and exposure of Trp residues. A capture ELISA measured the recognition of TT epitopes in the conjugates, using four rat monoclonal antibodies: 2 localised to the HC domain, and 2 of which were holotoxoid conformation-dependent. The conjugates had a wide range of average molecular masses ranging from 1.8×10(6) g/mol to larger than 20×10(6) g/mol. The panel of conjugates were found to be well folded, and did not have spectral features typical of aggregated TT. A partial correlation was found between molecular mass and epitope recognition. Recognition of the epitopes either on the HC domain or the whole toxoid was not necessarily hampered by the size of the molecule. Correlation was also found between the accessibility of Trp side chains and polysaccharide loading, suggesting also that a higher level of conjugated PS does not necessarily interfere with toxoid accessibility. There were different levels of carrier protein Trp side-chain and epitope accessibility that were localised to the HC domain; these were related to the saccharide type, despite the conjugates being independently manufactured. These findings extend our understanding of the molecular basis for carrier protein recognition in TT conjugate vaccines., (Crown Copyright © 2015. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
19. A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.
- Author
-
Gao F, Lockyer K, Burkin K, Crane DT, and Bolgiano B
- Subjects
- Drug Stability, Humans, Protein Stability, Temperature, Vaccines, Conjugate chemistry, Carrier Proteins chemistry, Chemical Phenomena, Pneumococcal Vaccines chemistry
- Abstract
Physico-chemical analysis of pneumococcal polysaccharide (PS)-protein conjugate vaccine components used for two commercially licensed vaccines was performed to compare the serotype- and carrier protein-specific stabilities of these vaccines. Nineteen different monovalent pneumococcal conjugates from commercial vaccines utilizing CRM197, diphtheria toxoid (DT), Protein D (PD) or tetanus toxoid (TT) as carrier proteins were incubated at temperatures up to 56°C for up to eight weeks or were subjected to freeze-thawing (F/T). Structural stability was evaluated by monitoring their size, integrity and carrier protein conformation. The molecular size of the vaccine components was well maintained for Protein D, TT and DT conjugates at -20°C, 4°C and F/T, and for CRM197 conjugates at 4°C and F/T. It was observed that four of the eight serotypes of Protein D conjugates tended to form high molecular weight complexes at 37°C or above. The other conjugated carrier proteins also appeared to form oligomers or 'aggregates' at elevated temperatures, but rarely when frozen and thawed. There was evidence of degradation in some of the conjugates as evidenced by the formation of lower molecular weight materials which correlated with measured free saccharide. In conclusion, pneumococcal-Protein D/TT/DT and most CRM197 bulk conjugate vaccines were stable when stored at 2-8°C, the recommended temperature. In common between the conjugates produced by the two manufacturers, serotypes 1, 5, and 19F were relatively less stable and 6B was the most stable, with types 7F and 23F also showing good stability.
- Published
- 2014
- Full Text
- View/download PDF
20. Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
- Author
-
Xie O, Bolgiano B, Gao F, Lockyer K, Swann C, Jones C, Delrieu I, Njanpop-Lafourcade BM, Tamekloe TA, Pollard AJ, and Norheim G
- Subjects
- Adolescent, Adult, Africa South of the Sahara, Chromatography, Gel, Chromatography, High Pressure Liquid, Enzyme-Linked Immunosorbent Assay, Humans, Immunoglobulin G immunology, Magnetic Resonance Spectroscopy, Molecular Sequence Annotation, Molecular Structure, Neisseria meningitidis classification, Neisseria meningitidis immunology, Polysaccharides, Bacterial immunology, Polysaccharides, Bacterial isolation & purification, Serotyping, Young Adult, Antibodies, Bacterial immunology, Neisseria meningitidis chemistry, Polysaccharides, Bacterial chemistry
- Abstract
Serogroup X Neisseria meningitidis (MenX) has recently emerged as a cause of localized disease outbreaks in sub-Saharan Africa. In order to prepare for vaccine development, MenX polysaccharide (MenX PS) was purified by standard methods and analyzed for identity and structure by NMR spectroscopy. This study presents the first full assignment of the structure of the MenX PS using (13)C, (1)H and (31)P NMR spectroscopy and total correlation spectroscopy (TOCSY) and (1)H-(13)C heteronuclear single quantum coherence (HSQC). Molecular size distribution analysis using HPLC-SEC with multi-angle laser light scattering (MALLS) found the single peak of MenX PS to have a weight-average molar mass of 247,000g/mol, slightly higher than a reference preparation of purified serogroup C meningococcal polysaccharide. MenX PS tended to be more thermostable than serogroup A PS. A method for the quantification of MenX PS was developed by use of high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). A novel and specific ELISA assay for quantification of human anti-MenX PS IgG based on covalent linkage of the MenX PS to functionally modified microtitre plates was developed and found valid for the assessment of the specific antibody concentrations produced in response to MenX vaccination or natural infection. The current work thus provides the necessary background for the development of a MenX PS-based vaccine to prevent meningococcal infection caused by bacteria bearing this capsule., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
21. Continuous negative extrathoracic pressure in neonatal respiratory failure.
- Author
-
Samuels MP, Raine J, Wright T, Alexander JA, Lockyer K, Spencer SA, Brookfield DS, Modi N, Harvey D, Bose C, and Southall DP
- Subjects
- Female, Humans, Infant, Newborn, Intensive Care Units, Neonatal, Intermittent Positive-Pressure Ventilation, Male, Outcome and Process Assessment, Health Care, Respiratory Distress Syndrome, Newborn complications, Respiratory Distress Syndrome, Newborn mortality, Respiratory Distress Syndrome, Newborn therapy, Ventilators, Negative-Pressure
- Abstract
Objective: In uncontrolled clinical trials, negative extrathoracic pressure has been shown to be an effective respiratory support. We aimed to assess its role in the context of current neonatal intensive care., Design: A randomized controlled trial, with sequential analysis of matched pairs of infants. Matching was undertaken by stratified randomization from 15 groups divided according to gestational age, oxygen requirement, and whether patients were intubated at 4 hours of age., Setting: Two neonatal intensive care units., Patients: Two hundred forty-four patients (birth weight 1.53 +/- 0.69 kg (mean +/- SD); gestational age 30.4 +/- 3.5 weeks) with respiratory failure., Interventions: Patients were randomized at 4 hours of age to receive either standard neonatal intensive care, or standard care plus continuous negative extrathoracic pressure (CNEP, -4 to -6 cmH2O) applied within a purpose-designed neonatal incubator. OUTCOME SCORES: Clinical scores were calculated for each infant at 56 days of age, or death if earlier. Scores included measures for mortality, respiratory outcome, the presence of cerebral ultrasound abnormalities, patent arterial duct, necrotizing enterocolitis, and retinopathy. The treatment given for the higher score for each pair was recorded and the cumulative net number of pairs favoring CNEP plotted in the sequential analysis to provide an ethical early termination strategy. Individual components of the outcome score and other secondary measurements were analyzed on completion of the trial., Results: The sequential analysis reached a decision boundary after 122 out of a possible maximum of 124 pairs were completed. The overall outcome score showed an overall significant benefit for CNEP. Secondary analysis showed that the use of CNEP was associated with an increase in mortality, cranial ultrasound abnormalities, and pneumothoraces, which were not statistically significant. However, 5% fewer patients were intubated (95% confidence interval [CI], 0-10), and the total duration of oxygen therapy among surviving infants at 56 days was lower (20.5 days, compared with 38.9 in controls; difference 18.4 days, 95% CI 3.8 to 33.0). Among all infants, the mean total duration of oxygen therapy was 18.3 days among CNEP-treated infants compared with 33.6 days among the controls (difference -15.3 days, 95% CI -0.2 to -30.4). This reduction in mean levels is entirely attributable to substantially fewer patients requiring prolonged oxygen therapy, the median duration of treatment being very similar in the two groups. As a result, commensurately fewer surviving infants showed chronic lung disease of prematurity., Conclusions: The use of continuous negative pressure improves the respiratory outcome for neonates with respiratory failure.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.